| Mrs Cynthia Brungardt, RPH | |
|
2424 N. Taylor Avenuee, Garden City, KS 67846 | |
| (620) 765-7047 | |
| (620) 765-7044 |
| Full Name | Mrs Cynthia Brungardt |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2424 N. Taylor Avenuee, Garden City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659812279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-11198 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cynthia Brungardt, RPH 2424 N Taylor Ave, Garden City, KS 67846-2627 Ph: (620) 765-7047 | Mrs Cynthia Brungardt, RPH 2424 N. Taylor Avenuee, Garden City, KS 67846 Ph: (620) 765-7047 |
News Archive
Using a series of gold nanorods, each with its own characteristic optical signature, researchers at Purdue University have developed a method for rapidly assaying the cellular composition of breast tumors.
New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease.
Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
Treatment of ductal carcinoma in situ (DCIS), a group of abnormal cells confined to the breast ducts, varies widely in the United States. Treatment ranges from potential over-treatment with aggressive surgical therapy to possible under-treatment by not providing radiation.
Researchers at Fox Chase Cancer Center have developed a new technique to speed discovery of drug targets in chemical genetics. Fox Chase researcher Jeffrey R. Peterson, Ph.D., and his colleagues describe a new way to swiftly find the proteins targeted by small molecule inhibitors during high-throughput screening (HTS) experiments. The new work offers a critical solution to a common stumbling block in this booming field of drug discovery.
› Verified 6 days ago
Baylee Hoskinson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 311 E Spruce St, Garden City, KS 67946 Phone: 620-271-3125 | |
Aimee Porterfield, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 E Kansas Ave, Garden City, KS 67846 Phone: 620-275-1957 Fax: 620-272-8218 | |
Dr. Grace Unruh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1305 E Kansas Ave, Garden City, KS 67846 Phone: 620-275-1957 Fax: 620-272-8218 | |
Robin M Stocking, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3010 Larue St, Garden City, KS 67846 Phone: 620-272-9023 | |
Seth Joel Langenegger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1211 Buffalo Jones Ave, Garden City, KS 67846 Phone: 620-275-0194 Fax: 620-272-8219 | |
Dr. Flint Russett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 E Spruce St, Department Of Pharmacy, Garden City, KS 67846 Phone: 620-272-2152 | |
Dr. Johnny Cao-nguyen, PHARMD/MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1211 Buffalo Jones Ave, Garden City, KS 67846 Phone: 620-275-0194 Fax: 620-275-8219 |